Larvol Delta - Zydus-Partners-with-Bioeq-for-US-Commercialisation-rights-for-NUFYMCO-an-Interchangeable-Biosimilar-to-Lucentis

Cimerli (ranibizumab-eqrn) - Amneal, Formycon, Coherus Oncology, Teva, Bio Usawa, Bioeq AG, Zydus Lifesci

https://www.prnewswire.com/news-releases/zydus-partners-with-bioeq-for-us-commercialisation-rights-for-nufymco-an-interchangeable-biosimilar-to-lucentis-302648783.html

Dec 23, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next